Mirum Pharmaceuticals Inc banner

Wall St Price Targets

MIRM Price Forecast
Based on 17 analysts

+65% Upside
from $94.61 today

Mirum Pharmaceuticals Inc (MIRM)’s 12-month stock price forecast through November 2027 has a consensus target of $156.57, implying 65% upside. The forecast is based on price targets from 17 Wall Street analysts.

MIRM Analyst Rating
Based on 14 analysts

avg. 4.71 of 5
Strong buy
10 71%
Buy
4 29%
Hold
0 0%
Sell
0 0%
Strong sell
0 0%

Analysts rate MIRM Strong buy, with 14 of 14 recommending Buy or Strong buy.

Mirum Pharmaceuticals Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is MIRM's stock price target?
Price Target
156.57 USD

According to Wall Street analysts, the average 1-year price target for MIRM is 156.57 USD with a low forecast of 127.26 USD and a high forecast of 212.1 USD.

What is the Revenue forecast for Mirum Pharmaceuticals Inc?
Projected CAGR
21%

The compound annual growth rate for Revenue over the next 8 years is 21%.

What is the Gross Profit forecast for Mirum Pharmaceuticals Inc?
Projected CAGR
22%

The compound annual growth rate for Gross Profit over the next 8 years is 22%.

Back to Top